{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:58:18Z","timestamp":1760029098329},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/mnh.0b013e328365adb1","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T15:43:28Z","timestamp":1381160608000},"page":"607-614","source":"Crossref","is-referenced-by-count":5,"title":["Renal sympathetic nerve ablation for the management of resistant hypertension"],"prefix":"10.1097","volume":"22","author":[{"given":"Alicia A.","family":"Thorp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn N.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus P.","family":"Schlaich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-4-20210205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.HYP.0000103630.72812.10","article-title":"Hypertension treatment and control in five European countries, Canada, and the United States.","volume":"43","author":"Wolf-Maier","year":"2004","journal-title":"Hypertension"},{"key":"R3-4-20210205","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics - 2011 update: a report from the American Heart Association.","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"R4-4-20210205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data.","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"R5-4-20210205","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"R6-4-20210205","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients.","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"R7-4-20210205","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States.","volume":"57","author":"Persell","year":"2011","journal-title":"Hypertension"},{"key":"R8-4-20210205","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"R9-4-20210205","doi-asserted-by":"crossref","first-page":"d4891","DOI":"10.1136\/bmj.d4891","article-title":"Management of hypertension: summary of NICE guidance.","volume":"343","author":"Krause","year":"2011","journal-title":"BMJ"},{"key":"R11-4-20210205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjhyper.2003.10.010","article-title":"Relationship between central sympathetic activity and stages of human hypertension.","volume":"17","author":"Smith","year":"2004","journal-title":"Am J Hypertens"},{"key":"R13-4-20210205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/01.HYP.0000103160.35395.9E","article-title":"Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation.","volume":"43","author":"Schlaich","year":"2004","journal-title":"Hypertension"},{"key":"R14-4-20210205","doi-asserted-by":"crossref","first-page":"R633","DOI":"10.1152\/ajpregu.00258.2005","article-title":"Physiology in perspective: the wisdom of the body. Neural control of the kidney.","volume":"289","author":"DiBona","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R15-4-20210205","first-page":"1192","article-title":"Innervation of the renal cortex.","volume":"37","author":"Barajas","year":"1978","journal-title":"Fed Proc"},{"key":"R16-4-20210205","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1139\/y92-099","article-title":"Renorenal reflexes: interaction between efferent and afferent renal nerve activity.","volume":"70","author":"Kopp","year":"1992","journal-title":"Can J Physiol Pharmacol"},{"key":"R17-4-20210205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1152\/japplphysiol.00832.2009","article-title":"The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.","volume":"108","author":"Esler","year":"2010","journal-title":"J Appl Physiol"},{"key":"R18-4-20210205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(53)91589-X","article-title":"Sympathectomy in the treatment of hypertension; review of 122 cases.","volume":"1","author":"Morrissey","year":"1953","journal-title":"Lancet"},{"key":"R19-4-20210205","first-page":"89","article-title":"Current status of lumbar sympathectomy.","volume":"42","author":"Allen","year":"1976","journal-title":"Am Surg"},{"key":"R20-4-20210205","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"R21-4-20210205","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4244\/EIJV8I9A166","article-title":"First-in-human use of the OneShot renal denervation system from Covidien.","volume":"8","author":"Ormiston","year":"2013","journal-title":"EuroIntervention"},{"key":"R22-4-20210205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4244\/EIJV8I1A10","article-title":"First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension.","volume":"8","author":"Mabin","year":"2012","journal-title":"EuroIntervention"},{"key":"R23-4-20210205","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/HJH.0b013e328352ce78","article-title":"ESH position paper: renal denervation - an interventional therapy of resistant hypertension.","volume":"30","author":"Schmieder","year":"2012","journal-title":"J Hypertens"},{"key":"R25-4-20210205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.111.00194","article-title":"Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension.","volume":"61","author":"Hering","year":"2013","journal-title":"Hypertension"},{"key":"R26-4-20210205","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.","volume":"57","year":"2011","journal-title":"Hypertension"},{"key":"R28-4-20210205","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"R29-4-20210205","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.112.130880","article-title":"Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.","volume":"126","author":"Esler","year":"2012","journal-title":"Circulation"},{"key":"R30-4-20210205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.112.193870","article-title":"Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension.","volume":"60","author":"Mahfoud","year":"2012","journal-title":"Hypertension"},{"key":"R31-4-20210205","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.109.138610","article-title":"Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.","volume":"54","author":"Schlaich","year":"2009","journal-title":"Hypertension"},{"key":"R32-4-20210205","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1681\/ASN.2008040402","article-title":"Sympathetic activation in chronic renal failure.","volume":"20","author":"Schlaich","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R33-4-20210205","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2011111062","article-title":"Renal denervation in moderate to severe CKD.","volume":"23","author":"Hering","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R35-4-20210205","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1152\/physrev.00007.2009","article-title":"Sympathetic nervous system overactivity and its role in the development of cardiovascular disease.","volume":"90","author":"Malpas","year":"2010","journal-title":"Physiol Rev"},{"key":"R36-4-20210205","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.","volume":"59","author":"Brandt","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R37-4-20210205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","article-title":"First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study.","volume":"162","author":"Davies","year":"2013","journal-title":"Int J Cardiol"},{"key":"R38-4-20210205","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/HYPERTENSIONAHA.112.200865","article-title":"Health-related quality of life after renal denervation in patients with treatment-resistant hypertension.","volume":"60","author":"Lambert","year":"2013","journal-title":"Hypertension"},{"key":"R39-4-20210205","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jacc.2012.05.036","article-title":"A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension.","volume":"60","author":"Pokushalov","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R40-4-20210205","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jacc.2012.08.959","article-title":"Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension.","volume":"60","author":"Brandt","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R41-4-20210205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0304-3940(87)90043-7","article-title":"Regrowth of lesioned dorsal root nerve fibers into the spinal cord of neonatal rats.","volume":"74","author":"Carlstedt","year":"1987","journal-title":"Neurosci Lett"},{"key":"R42-4-20210205","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa010519","article-title":"Effect of sympathetic reinnervation on cardiac performance after heart transplantation.","volume":"345","author":"Bengel","year":"2001","journal-title":"N Engl J Med"},{"key":"R43-4-20210205","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2012.07.029","article-title":"Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.","volume":"60","author":"Geisler","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R44-4-20210205","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1161\/HYPERTENSIONAHA.112.201186","article-title":"Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.","volume":"60","author":"Brinkmann","year":"2012","journal-title":"Hypertension"},{"key":"R45-4-20210205","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ccd.24557","article-title":"Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.","volume":"81","author":"Kaltenbach","year":"2013","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Current Opinion in Nephrology & Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNH.0b013e328365adb1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:30:04Z","timestamp":1620963004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041552-201311000-00004"}},"subtitle":["an update"],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0b013e328365adb1","relation":{},"ISSN":["1062-4821"],"issn-type":[{"value":"1062-4821","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}